Immunogenicity, reactogenicity and breakthrough infections after two doses of the inactivated CoronaVac vaccine among patients on dialysis: phase 4 study

Detalles Bibliográficos
Autores principales: Medina-Pestana, José, Teixeira, Cinthia Montenegro, Viana, Laila Almeida, Manfredi, Silvia Regina, Nakamura, Monica Rika, Lucena, Elizabeth França, Amiratti, Adriano Luiz, Tedesco-Silva, Helio, Covas, Dimas Tadeu, Cristelli, Marina Pontello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967539/
https://www.ncbi.nlm.nih.gov/pubmed/35371464
http://dx.doi.org/10.1093/ckj/sfab258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967539/
https://www.ncbi.nlm.nih.gov/pubmed/35371464
http://dx.doi.org/10.1093/ckj/sfab258

Ejemplares similares